Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Sunnybrook Health Sciences Centre
University Hospital, Angers
Washington University School of Medicine
Institut Jean-Godinot
Fondazione Italiana Linfomi - ETS
Huazhong University of Science and Technology
M.D. Anderson Cancer Center
University of Rochester
Clinica Universidad de Navarra, Universidad de Navarra
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Ascentage Pharma Group Inc.
Canadian Cancer Trials Group
CSPC Megalith Biopharmaceutical Co.,Ltd.
Indiana University
University Health Network, Toronto
Zhongnan Hospital
Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji
National Cancer Institute, Egypt
Tongji Hospital
First Affiliated Hospital of Ningbo University
Assistance Publique - Hôpitaux de Paris
University of Pennsylvania
Yonsei University
Medical College of Wisconsin
The First Affiliated Hospital with Nanjing Medical University
Medical College of Wisconsin
Affiliated Hospital of Jiangsu University
AbbVie
University Hospital, Basel, Switzerland